Molly Henderson - Net Worth and Insider Trading
Molly Henderson Net Worth
The estimated net worth of Molly Henderson is at least $1 Million dollars as of 2024-05-10. Molly Henderson is the CFO and CBO of Phathom Pharmaceuticals Inc and owns about 97,174 shares of Phathom Pharmaceuticals Inc (PHAT) stock worth over $980,486. Molly Henderson is the CFO of UroGen Pharma Ltd and owns about 5,248 shares of UroGen Pharma Ltd (URGN) stock worth over $67,909. Molly Henderson is also the CBFO of VirtualScopics Inc and owns about 14,400 shares of VirtualScopics Inc (VSCP) stock worth over $58,176. Details can be seen in Molly Henderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Molly Henderson has not made any transactions after 2024-04-08 and currently still holds the listed stock(s).
Transaction Summary of Molly Henderson
Molly Henderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Molly Henderson owns 5 companies in total, including UroGen Pharma Ltd (URGN) , Advaxis Inc (ADXS) , and Iovance Biotherapeutics Inc (IOVA) among others .
Click here to see the complete history of Molly Henderson’s form 4 insider trades.
Insider Ownership Summary of Molly Henderson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2022-01-31 | Chief Financial Officer |
| ADXS | Advaxis Inc | 2018-06-06 | Executive Vice President & CFO |
| IOVA | Iovance Biotherapeutics Inc | 2015-06-08 | Chief Financial Officer |
 | | 2013-01-29 | Chief Business/Financial Off. |
| | 2024-04-08 | CFO and CBO |
Molly Henderson Latest Holdings Summary
Molly Henderson currently owns a total of 3 stocks. Among these stocks, Molly Henderson owns 97,174 shares of Phathom Pharmaceuticals Inc (PHAT) as of April 8, 2024, with a value of $980,486 and a weighting of 88.61%. Molly Henderson owns 5,248 shares of UroGen Pharma Ltd (URGN) as of January 31, 2022, with a value of $67,909 and a weighting of 6.14%. Molly Henderson also owns 14,400 shares of VirtualScopics Inc (VSCP) as of June 19, 2012, with a value of $58,176 and a weighting of 5.26%.
Latest Holdings of Molly Henderson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals Inc | 2024-04-08 | 97,174 | 10.09 | 980,486 |
| URGN | UroGen Pharma Ltd | 2022-01-31 | 5,248 | 12.94 | 67,909 |
| VSCP | VirtualScopics Inc | 2012-06-19 | 14,400 | 4.04 | 58,176 |
Holding Weightings of Molly Henderson
Molly Henderson Form 4 Trading Tracker
According to the SEC Form 4 filings, Molly Henderson has made a total of 9 transactions in Phathom Pharmaceuticals Inc (PHAT) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Phathom Pharmaceuticals Inc is the sale of 3,435 shares on April 8, 2024, which brought Molly Henderson around $38,129.
According to the SEC Form 4 filings, Molly Henderson has made a total of 3 transactions in UroGen Pharma Ltd (URGN) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in UroGen Pharma Ltd is the sale of 331 shares on January 31, 2022, which brought Molly Henderson around $2,509.
According to the SEC Form 4 filings, Molly Henderson has made a total of 0 transactions in VirtualScopics Inc (VSCP) over the past 5 years. The most-recent trade in VirtualScopics Inc is the acquisition of 8,000 shares on June 19, 2012, which cost Molly Henderson around $7,200.
Insider Trading History of Molly Henderson
- 1
Molly Henderson Trading Performance
GuruFocus tracks the stock performance after each of Molly Henderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Molly Henderson is -2.5%. GuruFocus also compares Molly Henderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Molly Henderson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Molly Henderson's insider trading performs compared to the benchmark.
Performance of Molly Henderson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.69 | | | | | |
| Relative Return to S&P 500(%) | 6.3 | | | | | |
Molly Henderson Ownership Network
Molly Henderson Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Molly Henderson is the Chief Financial Officer of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include Chief Medical Officer Mark Schoenberg , General Counsel Jason Drew Smith , and Chief Financial Officer Dong Kim .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Molly Henderson made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 21,478 shares made by Mark Schoenberg , and a net sale of 15,422 shares made by Jason Drew Smith .
In summary, during the past 3 months, insiders sold 12,000 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 36,900 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 36,900 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Molly Henderson Mailing Address
Above is the net worth, insider trading, and ownership report for Molly Henderson. You might contact Molly Henderson via mailing address: 305 College Road East, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
